Expression Pattern of Polycomb Group Proteins EZH1, EZH2 and Bmi1 in Low Grade Small B-Cell Lymphomas

被引:0
|
作者
Nazarullah, Alia [1 ]
Martowski, Andrew [1 ]
Alkan, Serhan [1 ]
Huang, Qin [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1463
引用
收藏
页码:367A / 367A
页数:1
相关论文
共 50 条
  • [41] Novel epigenetic approach to relapsed mantle cell lymphoma based on dual inhibition of EZH1/EZH2
    Fujita, Shuhei
    Kagiyama, Yuki
    Honma, Daisuke
    Adachi, Nobuaki
    Araki, Kazushi
    Kitabayashi, Issay
    CANCER RESEARCH, 2017, 77
  • [42] DNA Methyltransferase Controls Stem Cell Aging by Regulating BMI1 and EZH2 through MicroRNAs
    So, Ah-Young
    Jung, Ji-Won
    Lee, Seunghee
    Kim, Hyung-Sik
    Kang, Kyung-Sun
    PLOS ONE, 2011, 6 (05):
  • [43] Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
    Xun Jin
    Leo J Y Kim
    Qiulian Wu
    Lisa C Wallace
    Briana C Prager
    Tanwarat Sanvoranart
    Ryan C Gimple
    Xiuxing Wang
    Stephen C Mack
    Tyler E Miller
    Ping Huang
    Claudia L Valentim
    Qi-gang Zhou
    Jill S Barnholtz-Sloan
    Shideng Bao
    Andrew E Sloan
    Jeremy N Rich
    Nature Medicine, 2017, 23 : 1352 - 1361
  • [44] Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
    Jin, Xun
    Kim, Leo J. Y.
    Wu, Qiulian
    Wallace, Lisa C.
    Prager, Briana C.
    Sanvoranart, Tanwarat
    Gimple, Ryan C.
    Wang, Xiuxing
    Mack, Stephen C.
    Miller, Tyler E.
    Huang, Ping
    Valentim, Claudia L.
    Zhou, Qi-gang
    Barnholtz-Sloan, Jill S.
    Bao, Shideng
    Sloan, Andrew E.
    Rich, Jeremy N.
    NATURE MEDICINE, 2017, 23 (11) : 1352 - +
  • [45] Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas
    Bisserier, Malik
    Wajapeyee, Narendra
    BLOOD, 2018, 131 (19) : 2125 - 2137
  • [46] Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
    Raman, JD
    Mongan, NP
    Tickoo, SK
    Boorjian, SA
    Scherr, DS
    Gudas, LJ
    JOURNAL OF UROLOGY, 2006, 175 (04): : 196 - 197
  • [47] TARGETING GLIOMA STEM CELLS THROUGH COMBINED BMI1 AND EZH2 INHIBITION
    Jin, Xun
    Kim, Leo
    Wu, Qiulian
    Wallace, Lisa C.
    Prager, Briana
    Sanvoranart, Tanwarat
    Gimple, Ryan
    Mack, Stephen
    Miller, Tyler E.
    Huang, Ping
    Barnholtz-Sloan, Jill
    Bao, Shideng
    Sloan, Andrew
    Rich, Jeremy
    NEURO-ONCOLOGY, 2017, 19 : 80 - 80
  • [48] EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
    Porazzi, Patrizia
    Nason, Siena
    Yang, Ziqi
    Carturan, Alberto
    Ghilardi, Guido
    Guruprasad, Puneeth
    Patel, Ruchi P.
    Tan, Melody
    Padmanabhan, Anushka Anant
    Lemoine, Jean
    Fardella, Eugenio
    Zhang, Yunlin
    Pajarillo, Raymone
    Chen, Linhui
    Ugwuanyi, Ositadimma
    Markowitz, Kelly
    Delman, Devora
    Angelos, Mathew G.
    Shestova, Olga
    Isshiki, Yusuke
    Blanchard, Tatiana
    Beguelin, Wendy
    Melnick, Ari M.
    Linette, Gerald P.
    Beatty, Gregory L.
    Carreno, Beatriz M.
    Cohen, Ivan J.
    Paruzzo, Luca
    Schuster, Stephen J.
    Ruella, Marco
    CANCER CELL, 2025, 43 (03)
  • [49] Expression of human polycomb-group complexes containing BMI-1 and EZH2 is progressively disturbed in breast cancer development
    Mommers, ECM
    van Diest, PJ
    Fieret, E
    Blokzijl, T
    Hamer, K
    Otte, AP
    Meijer, CJLM
    Raaphorst, FM
    JOURNAL OF PATHOLOGY, 2001, 193 : 30A - 30A
  • [50] Co-expression of BMI-1 and EZH2 polycomb-group proteins in cycling cells of T-NHL suggests that BMI-1 overexpression contributes to lymphomagenesis
    Raaphorst, FM
    Van Kemenade, FJ
    Blokzijl, T
    Fieret, JH
    Hamer, KM
    Otte, AP
    Meijer, CJLM
    JOURNAL OF PATHOLOGY, 2001, 193 : 17A - 17A